<i>Hepatology</i>｜Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy

doi:10.3969/j.issn.1001-5256.2022.09.gwjpwzjj2

Volume 38 Issue 9

Sep. 2022

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(9): 2033-2033

PDF( 900 KB)

Hepatology｜Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy

DOI: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj2

Published Date: 2022-09-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Hepatology｜Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2
[2]	Chun CHEN, Kexin WANG, Mengwen HE, Le LI, Chunyan WANG, Yan LIU, Dong JI. Silencing essential meiotic endonuclease 1 inhibits the proliferation of liver cancer cells： A study of related mechanisms[J]. Journal of Clinical Hepatology, 2024, 40(5): 982-988. doi: 10.12449/JCH240518
[3]	Hepatology｜Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(7): 1333-1333. doi: 10.12449/JCH2407.gwqkjpwzjj2
[4]	Journal of Gastroenterology and Hepatology｜Compared with chemotherapy alone as the first-line treatment, PD-1 inhibitor combined with chemotherapy can significantly improve the median progression-free survival time of patients with metastatic or recurrent cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(2): 401-401. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj5
[5]	Heng ZHU, Weizong KONG, Guiqun HUANG, Yu BAI, Yingchun WANG. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2010-2015. doi: 10.3969/j.issn.1001-5256.2022.09.013
[6]	Journal of Hepatology｜PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 698-698. doi: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj2
[7]	Hepatology｜Lenvatinib exerts a therapeutic effect on hepatocellular carcinoma by targeting fibroblast growth factor receptor 4 to reduce PD-1[J]. Journal of Clinical Hepatology, 2022, 38(2): 435-435. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj8
[8]	Xi CAO, Yanling SUN, Cuiying CHEN, Yiwei XIAO, Kuanhui XIANG, Xueen LIU, Hui ZHUANG. Association between the alteration of serum N-glycan profile and the change of glycosyltransferase expression in liver tissue in patients with hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(6): 1336-1341. doi: 10.3969/j.issn.1001-5256.2021.06.024
[10]	Lu JiaZhen, Xu WenJuan, Cai YiLing, Ao ShaoJun, Ding RongRong, Zhang MingQing. ECHS1, epidermal growth factor, and low-glucose conditions promote the invasion and metastasis of hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2018, 34(7): 1481-1486. doi: 10.3969/j.issn.1001-5256.2018.07.023
[11]	Zhang ShaoRen, Hu JingXian, Fan XiaoMing. Effect of ghrelin O-acyltransferase inhibition by small interfering RNA on hepatocyte fatty degeneration and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(5): 1060-1067. doi: 10.3969/j.issn.1001-5256.2018.05.027
[14]	Song JinYun, Sun Mei, Li JiaYan, Wang JianFang, Wu XuPing. Role of UGT1A1 gene polymorphism in the pathogenesis of Gilbert syndrome[J]. Journal of Clinical Hepatology, 2016, 32(3): 609-612. doi: 10.3969/j.issn.1001-5256.2016.03.047
[15]	Zhang JiCai, Yu ZongTao, Lyu Jun, Li HaiPing, Gao Bo. Relationship between HBV infection and DNMT expression in liver cancer tissues[J]. Journal of Clinical Hepatology, 2013, 29(8): 620-623. doi: 10.3969/j.issn.1001-5256.2013.08.017
[16]	Li HaiPing, Yu ZongTao, Fan JinBo, Gao Bo, Zhang JiCai. DNMT expression in hepatocellular cancer[J]. Journal of Clinical Hepatology, 2013, 29(7): 525-528. doi: 1001-5256 (2013) 07-0525-04
[17]	Wang YingChun, Liu YanFang, Zhu RuiPing, Song XinXin, Li XiaoHuan. Expression of histone deacetylase 1 and matrix metalloproteinase-2 in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2012, 28(4): 276-278+288.
[18]	Chang BinXia, You ShaoLi, Li BaoSen, Mao PanYong, Xin ShaoJie. Construction and evaluation of recombinant plasmids expressing CYP3A4 and GSTA1[J]. Journal of Clinical Hepatology, 2012, 28(9): 697-700.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (317) PDF downloads(47)

Hepatology｜Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy

DOI: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Hepatology｜Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy

DOI: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content